PLGA Microparticles Encapsulating Prostaglandin E₁-Hydroxypropyl-β-cyclodextrin (PGE₁-HPβCD) Complex for the Treatment of Pulmonary Arterial Hypertension (PAH)

By Gupta Vivek   Davis Marauo   Hope-Weeks Louisa   Ahsan Fakhrul  

Pharmaceutical Research, Vol. 28, Iss. 7, 2011-07 ,pp. : 1733-1749

Springer Publishing Company

Access to resources Recommend Favorite

Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery

By  

Current Pharmaceutical Design, Vol. 22, Iss. 17, 2016-05 ,pp. : 2463-2469

Bentham Science Publishers

Access to resources Recommend Favorite

Preparation of Large Porous Deslorelin-PLGA Microparticles with Reduced Residual Solvent and Cellular Uptake Using a Supercritical Carbon Dioxide Process

By Koushik Kavitha   Kompella Uday B.  

Pharmaceutical Research, Vol. 21, Iss. 3, 2004-03 ,pp. : 524-535

Springer Publishing Company

Access to resources Recommend Favorite

Preparation of Tiagabine HCl/2-HP&bgr;CD Complex Pellets by Extrusion-Spheronization Using Glycerol Monostearate as Pellet-Aid

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 1, 2010-01 ,pp. : 63-69

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Diclofenac and Hydroxypropyl‐β‐Cyclodextrin (HPβCD) Following Administration of Injectable HPβCD‐Diclofenac in Subjects With Mild to Moderate Renal Insufficiency or Mild Hepatic Impairment

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 110-122

John Wiley & Sons Inc

Access to resources Recommend Favorite